🎉 Gate Square Growth Points Summer Lucky Draw Round 1️⃣ 2️⃣ Is Live!
🎁 Prize pool over $10,000! Win Huawei Mate Tri-fold Phone, F1 Red Bull Racing Car Model, exclusive Gate merch, popular tokens & more!
Try your luck now 👉 https://www.gate.com/activities/pointprize?now_period=12
How to earn Growth Points fast?
1️⃣ Go to [Square], tap the icon next to your avatar to enter [Community Center]
2️⃣ Complete daily tasks like posting, commenting, liking, and chatting to earn points
100% chance to win — prizes guaranteed! Come and draw now!
Event ends: August 9, 16:00 UTC
More details: https://www
NASDAQ-listed company 180 Life Sciences $ATNF announced that it has signed a PIPE private sale protocol, planning to raise $425 million.
To execute the $ETH strategic plan, the new company will be renamed #ETHZilla# .
The issue price is $2.65 per share, expected to be completed on August 1, 2025.
After the announcement was released, 180 Life Sciences' stock price opened high and then fell, peaking above $4.7, and is currently reported at $2.7, a 43% retracement from its high.
180 Life Sciences also plans to issue bonds of up to $150 million.
Electric Capital will act as the external asset manager, designing high-yield DeFi strategies.
Exceeds traditional ETH staking yields, such as staking, lending, LP, etc.
There are more than 60 PIPE investors, covering traditional financial and crypto-native institutions, including:
Electric Capital, Polychain Capital, GSR, Omicron, and Lido co-founder Konstantin Lomashuk, Eigen Layer founder Sreeram Kannan, Silagadze, Frax co-founder Sam Kazemian, Compound founder Robert Leshner, Gauntlet founder Tarun Chitra, among others.
A rough look shows that most of the investors are the founders of DeFi protocols, and they are expected to be upstream and downstream partners of ETHZilla.